507 related articles for article (PubMed ID: 32194554)
1. Opioid Receptors in Immune and Glial Cells-Implications for Pain Control.
Machelska H; Celik MÖ
Front Immunol; 2020; 11():300. PubMed ID: 32194554
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomic study of the role of the nociceptin/orphanin FQ receptor and opioid receptors in diabetic hyperalgesia.
Rutten K; Tzschentke TM; Koch T; Schiene K; Christoph T
Eur J Pharmacol; 2014 Oct; 741():264-71. PubMed ID: 25169429
[TBL] [Abstract][Full Text] [Related]
3. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat.
Tzschentke TM; Rutten K
Neuropharmacology; 2018 Feb; 129():100-108. PubMed ID: 29155273
[TBL] [Abstract][Full Text] [Related]
4. Evidence for nociceptin/orphanin FQ (NOP) but not µ (MOP), δ (DOP) or κ (KOP) opioid receptor mRNA in whole human blood.
Al-Hashimi M; McDonald J; Thompson JP; Lambert DG
Br J Anaesth; 2016 Mar; 116(3):423-9. PubMed ID: 26865135
[TBL] [Abstract][Full Text] [Related]
5. Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic pain.
Rutten K; Schröder W; Christoph T; Koch T; Tzschentke TM
Eur J Pharmacol; 2018 May; 827():41-48. PubMed ID: 29524385
[TBL] [Abstract][Full Text] [Related]
6. N/OFQ-NOP System in Peripheral and Central Immunomodulation.
Kadhim S; Bird MF; Lambert DG
Handb Exp Pharmacol; 2019; 254():297-311. PubMed ID: 30771012
[TBL] [Abstract][Full Text] [Related]
7. Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders.
Ubaldi M; Cannella N; Borruto AM; Petrella M; Micioni Di Bonaventura MV; Soverchia L; Stopponi S; Weiss F; Cifani C; Ciccocioppo R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884757
[TBL] [Abstract][Full Text] [Related]
8. Human peripheral blood mononuclear cells express nociceptin/orphanin FQ, but not mu, delta, or kappa opioid receptors.
Williams JP; Thompson JP; McDonald J; Barnes TA; Cote T; Rowbotham DJ; Lambert DG
Anesth Analg; 2007 Oct; 105(4):998-1005, table of contents. PubMed ID: 17898379
[TBL] [Abstract][Full Text] [Related]
9. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.
Sukhtankar DD; Zaveri NT; Husbands SM; Ko MC
J Pharmacol Exp Ther; 2013 Jul; 346(1):11-22. PubMed ID: 23652222
[TBL] [Abstract][Full Text] [Related]
10. Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.
Taylor AM; Roberts KW; Pradhan AA; Akbari HA; Walwyn W; Lutfy K; Carroll FI; Cahill CM; Evans CJ
Br J Pharmacol; 2015 Jan; 172(2):691-703. PubMed ID: 24923251
[TBL] [Abstract][Full Text] [Related]
11. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
[TBL] [Abstract][Full Text] [Related]
12. Central N/OFQ-NOP Receptor System in Pain Modulation.
Kiguchi N; Ding H; Ko MC
Adv Pharmacol; 2016; 75():217-43. PubMed ID: 26920014
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse.
Kiguchi N; Ding H; Ko MC
J Neurosci Res; 2022 Jan; 100(1):191-202. PubMed ID: 32255240
[TBL] [Abstract][Full Text] [Related]
14. Nociceptin/Orphanin FQ receptor expression in primary human umbilical vein endothelial cells is not regulated by exposure to breast cancer cell media or angiogenic stimuli.
Giakomidi D; Khemiri S; Mahbuba W; McVey DG; Al-Janabi F; Guerrini R; Calo G; Ye S; Lambert DG
BJA Open; 2022 Dec; 4():100110. PubMed ID: 37588788
[TBL] [Abstract][Full Text] [Related]
15. Dynorphin/KOP and nociceptin/NOP gene expression and epigenetic changes by cocaine in rat striatum and nucleus accumbens.
Caputi FF; Di Benedetto M; Carretta D; Bastias del Carmen Candia S; D'Addario C; Cavina C; Candeletti S; Romualdi P
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():36-46. PubMed ID: 24184686
[TBL] [Abstract][Full Text] [Related]
16. Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation model.
Christoph T; Raffa R; De Vry J; Schröder W
Pharmacol Res Perspect; 2018 Dec; 6(6):e00444. PubMed ID: 30519474
[TBL] [Abstract][Full Text] [Related]
17. Nociceptin/orphanin FQ receptor and pain: Feasibility of the fourth opioid family member.
Di Cesare Mannelli L; Micheli L; Ghelardini C
Eur J Pharmacol; 2015 Nov; 766():151-4. PubMed ID: 26277324
[TBL] [Abstract][Full Text] [Related]
18. Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells.
Caputi FF; Lattanzio F; Carretta D; Mercatelli D; Candeletti S; Romualdi P
J Mol Neurosci; 2013 Oct; 51(2):532-8. PubMed ID: 23715695
[TBL] [Abstract][Full Text] [Related]
19. Distribution of functional opioid receptors in human dorsal root ganglion neurons.
Moy JK; Hartung JE; Duque MG; Friedman R; Nagarajan V; Loeza-Alcocer E; Koerber HR; Christoph T; Schröder W; Gold MS
Pain; 2020 Jul; 161(7):1636-1649. PubMed ID: 32102022
[TBL] [Abstract][Full Text] [Related]
20. Roles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates.
Cremeans CM; Gruley E; Kyle DJ; Ko MC
J Pharmacol Exp Ther; 2012 Oct; 343(1):72-81. PubMed ID: 22743574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
